nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—KCNK1—Potassium Channels—KCNJ5—adrenal gland cancer	0.103	0.115	CbGpPWpGaD
Quinidine barbiturate—Quinine—ABCB1—adrenal gland cancer	0.0451	0.439	CrCbGaD
Quinidine barbiturate—KCNK1—Neuronal System—KCNJ5—adrenal gland cancer	0.0451	0.0502	CbGpPWpGaD
Quinidine barbiturate—GABRA2—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0409	0.0456	CbGpPWpGaD
Quinidine barbiturate—Quinidine—ABCB1—adrenal gland cancer	0.0396	0.386	CrCbGaD
Quinidine barbiturate—GABRA1—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0349	0.0389	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0333	0.0372	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Potassium Channels—KCNJ5—adrenal gland cancer	0.0311	0.0347	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.0274	0.0305	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0267	0.0298	CbGpPWpGaD
Quinidine barbiturate—GRIA2—N-cadherin signaling events—CDC42—adrenal gland cancer	0.0257	0.0287	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0228	0.0254	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0201	0.0224	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0188	0.021	CbGpPWpGaD
Quinidine barbiturate—Phenobarbital—ABCB1—adrenal gland cancer	0.0179	0.175	CrCbGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0177	0.0198	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—PRKACA—adrenal gland cancer	0.0173	0.0192	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—IGF2—adrenal gland cancer	0.0166	0.0185	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.016	0.0179	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—KCNJ5—adrenal gland cancer	0.0154	0.0172	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.0147	0.0164	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0141	0.0158	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—KCNJ5—adrenal gland cancer	0.0136	0.0152	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0121	0.0134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0119	0.0133	CbGpPWpGaD
Quinidine barbiturate—GRIA2—N-cadherin signaling events—CTNNB1—adrenal gland cancer	0.0118	0.0132	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—KCNJ5—adrenal gland cancer	0.0108	0.0121	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0102	0.0114	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—BRAF—adrenal gland cancer	0.00931	0.0104	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—KCNJ5—adrenal gland cancer	0.00924	0.0103	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00856	0.00954	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00849	0.00946	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00829	0.00924	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NR5A1—adrenal gland cancer	0.00776	0.00865	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0077	0.00858	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00721	0.00804	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0066	0.00735	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00615	0.00685	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—BAD—adrenal gland cancer	0.00593	0.0066	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—PRKACA—adrenal gland cancer	0.0059	0.00657	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00564	0.00628	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00552	0.00615	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00542	0.00604	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—PRKACA—adrenal gland cancer	0.00521	0.00581	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00502	0.0056	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MED12—adrenal gland cancer	0.00466	0.0052	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00462	0.00515	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00458	0.0051	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00441	0.00492	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—PRKACA—adrenal gland cancer	0.00415	0.00463	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00415	0.00462	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CDC42—adrenal gland cancer	0.00405	0.00451	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00395	0.00441	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.0039	0.00435	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—EGFR—adrenal gland cancer	0.00389	0.00434	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00389	0.00433	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00388	0.00433	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00371	0.00414	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—PRKACA—adrenal gland cancer	0.00354	0.00395	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00352	0.00393	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00333	0.00371	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00331	0.00369	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00323	0.0036	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—BRAF—adrenal gland cancer	0.00318	0.00354	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00312	0.00348	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00301	0.00335	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00292	0.00326	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CDC42—adrenal gland cancer	0.00289	0.00322	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00284	0.00316	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—BRAF—adrenal gland cancer	0.00281	0.00313	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00268	0.00299	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00258	0.00287	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00258	0.00287	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00253	0.00282	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00249	0.00278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00247	0.00275	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—BRAF—adrenal gland cancer	0.00224	0.00249	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00223	0.00249	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.0022	0.00245	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—BRAF—adrenal gland cancer	0.00191	0.00213	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.0019	0.00212	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00181	0.00202	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00178	0.00198	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00174	0.00193	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00172	0.00192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0017	0.0019	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00156	0.00174	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00154	0.00172	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00154	0.00172	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00152	0.0017	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00152	0.00169	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00151	0.00169	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—adrenal gland cancer	0.00147	0.00164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00142	0.00158	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00141	0.00157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00138	0.00154	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00138	0.00153	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00135	0.0015	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00133	0.00148	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00133	0.00148	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.0012	0.00134	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00105	0.00117	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—adrenal gland cancer	0.00105	0.00117	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000988	0.0011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000923	0.00103	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000913	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000882	0.000983	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000838	0.000934	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000835	0.00093	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000813	0.000906	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000801	0.000893	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000775	0.000864	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000775	0.000864	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000765	0.000852	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000594	0.000662	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000584	0.000651	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000578	0.000644	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000539	0.000601	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000495	0.000552	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000477	0.000532	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000473	0.000527	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000461	0.000514	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000422	0.00047	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000397	0.000443	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000346	0.000385	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000342	0.000381	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000335	0.000374	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000319	0.000355	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000315	0.000351	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000305	0.00034	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.00023	0.000256	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000227	0.000253	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000183	0.000204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.00018	0.000201	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000151	0.000169	CbGpPWpGaD
